Source: Letters in Drug Design & Discovery. Unidade: FCFRP
Subjects: TRYPANOSOMA CRUZI, TRIPANOSSOMICIDAS, ENSAIO CLÍNICO, CITOTOXICIDADE IMUNOLÓGICA, ANTIPARASITÁRIOS
ABNT
LIMA, Camilo Henrique da Silva et al. Anti-Trypanosoma cruzi activity and molecular docking studies of 1Hpyrazolo[ 3, 4-b]pyridine derivatives. Letters in Drug Design & Discovery, v. 17, n. 2, p. 184-191, 2020Tradução . . Disponível em: https://doi.org/10.2174/1570180816666190305141733. Acesso em: 29 ago. 2024.APA
Lima, C. H. da S., Soares, J. C. de A. V., Ribeiro, J. L. de S., Muri, E. M. F., Albuquerque, S. de, & Dias, L. R. S. (2020). Anti-Trypanosoma cruzi activity and molecular docking studies of 1Hpyrazolo[ 3, 4-b]pyridine derivatives. Letters in Drug Design & Discovery, 17( 2), 184-191. doi:10.2174/1570180816666190305141733NLM
Lima CH da S, Soares JC de AV, Ribeiro JL de S, Muri EMF, Albuquerque S de, Dias LRS. Anti-Trypanosoma cruzi activity and molecular docking studies of 1Hpyrazolo[ 3, 4-b]pyridine derivatives [Internet]. Letters in Drug Design & Discovery. 2020 ; 17( 2): 184-191.[citado 2024 ago. 29 ] Available from: https://doi.org/10.2174/1570180816666190305141733Vancouver
Lima CH da S, Soares JC de AV, Ribeiro JL de S, Muri EMF, Albuquerque S de, Dias LRS. Anti-Trypanosoma cruzi activity and molecular docking studies of 1Hpyrazolo[ 3, 4-b]pyridine derivatives [Internet]. Letters in Drug Design & Discovery. 2020 ; 17( 2): 184-191.[citado 2024 ago. 29 ] Available from: https://doi.org/10.2174/1570180816666190305141733